PRP Therapies-Is It Time for Potency Assays? Letter to the Editor.

about

PRP Therapies-Is It Time for Potency Assays? Letter to the Editor.

Item

http://www.wikidata.org/entity/Q51067961

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

PRP Therapies-Is It Time for Potency Assays? Letter to the Editor.

@en

PRP Therapies-Is It Time for Potency Assays? Letter to the Editor.

@nl

type

Item

label

PRP Therapies-Is It Time for Potency Assays? Letter to the Editor.

@en

PRP Therapies-Is It Time for Potency Assays? Letter to the Editor.

@nl

prefLabel

PRP Therapies-Is It Time for Potency Assays? Letter to the Editor.

@en

PRP Therapies-Is It Time for Potency Assays? Letter to the Editor.

@nl

P1476

PRP Therapies-Is It Time for Potency Assays? Letter to the Editor

@en

P2093

Gorka Orive

http://www.w3.org/2001/XMLSchema#string

P2860

Customized platelet-rich plasma with transforming growth factor β1 neutralization antibody to reduce fibrosis in skeletal muscle

High-throughput proteomic characterization of plasma rich in growth factors (PRGF-Endoret)-derived fibrin clot interactome.

A robust potency assay highlights significant donor variation of human mesenchymal stem/progenitor cell immune modulatory capacity and extended radio-resistance.

Regenerative medicine: then and now--an update of recent history into future possibilities.

Potency assay development for cellular therapy products: an ISCT review of the requirements and experiences in the industry.

Potency evaluation of tissue engineered and regenerative medicine products.

Platelet-Rich Plasma with Basic Fibroblast Growth Factor for Treatment of Wrinkles and Depressed Areas of the Skin.

Cell-based therapeutic products: potency assay development and application.

Cell-based Assay System for Predicting Bone Regeneration in Patient Affected by Aseptic Nonunion and Treated with Platelet Rich Fibrin.

P304

NP63-NP64

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/0363546516676460

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Roberto Prado

Eduardo Anitua

P577

2016-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27836880

http://www.w3.org/2001/XMLSchema#string